Platelet-to-lymphocyte ratio predicts long-term survival in laryngeal cancer
European Archives of Oto-Rhino-Laryngology Jan 10, 2018
Mao Y, et al. - The goal of this paper was to detect the high-risk patients according to a preoperatively determined signature of the platelet-to-lymphocyte ratio (PLR) of > 193.55, as an indicator of poor treatment outcome in laryngeal squamous cell carcinoma (LSCC) patients. As per findings, poor outcomes were experienced by patients with PLR > 193.55. These patients represented malnutrition and more advanced cancer stage.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries